Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: Receptor transactivation and prereceptor metabolism by 11β-hydroxysteroid-dehydrogenases

Hormone and Metabolic Research

Volumn 36, Issue 6, 2004, Pages 423-429

  Diederich, S ^a,b   Scholz, T ^a   Eigendorff, E ^a   Bumke Vogt, Ch ^a   Quinkler, M ^a   Exner, P ^a   Pfeiffer, A F H ^a,b   Oelkers, W ^a   Bahr V ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Renal immunosuppression; Synthetic steroids; Target organ action

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; BETAMETHASONE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTOR; HYDROCORTISONE; ISOFLUPREDONE; LUCIFERASE; METHYLPREDNISOLONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; PREDNISOLONE; PREDNISONE; STEROID;

CHO CELL; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME METABOLISM; ENZYME REGULATION; FLUORINATION; GENETIC TRANSFECTION; HORMONE ACTION; HORMONE METABOLISM; MEASUREMENT; MICROSOME; OXIDATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; KIDNEY; MICROSOMES, LIVER; MINERALOCORTICOIDS; ORGAN SPECIFICITY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID;

VECTORS;

EID: 3142763014     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814578     Document Type: Conference Paper

References (31)

1. Fried J, Borman A. Synthetic derivates of cortical hormones. Vitam Horm 1958; 16: 303-374
2. Ballard PL, Carter JP, Graham BS, Baxter JD. A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinol Metab 1975; 41: 290-304
3. Agarwal MK, Mirshahi M. General overview of mineralocorticoid hormone action. Pharmacol Ther 1999; 84: 273-326
4. Quinkler M, Oelkers W, Diederich S. Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues. Eur J Endocrinol 2001; 144: 87-97
5. Whorwood CB, Franklyn JA, Sheppard MC, Stewart PM. Tissue localization of 11 beta-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J Steroid Biochem Mol Biol 1992; 41: 21-28
6. Nomura S, Fujitaka M, Sakura N, Ueda K. Circadian rhythms in plasma cortisone and cortisol and the cortisone/cortisol ratio. Clin Chim Acta 1997; 266: 83-91
7. Whorwood CB, Mason JI, Ricketts ML, Howie AJ, Stewart PM. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse- transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Molecular and Cellular Endocrinology 1995; 110: R7-R12
8. 1 cells model 11β-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. Endocrinology 1995; 136: 5561-5569
9. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 58-68
10. Oelkers W, Diederich S, Bähr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 1992; 75: 259-264
11. Diederich S, Hanke B, Burkhardt P, Müller M, Schöneshöfer M, Bähr V, Oelkers W. Metabolism of synthetic corticosteroids by 11β-hydroxysteroid-dehydrogenases in man. Steroids 1998; 63: 271-277
12. Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bähr V, Oelkers W. In the search for specific inhibitors of human 11beta-hydroxysteroid- dehydrogenases: chenodeoxycholic acid selectively inhibits 11beta-HSD-I. Eur J Endocrinol 2000; 142: 200-207
13. Diederich S, Eigendorff E, Burkhard P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bähr V. 11β-hydroxysteroid dehydrogenase type 1 and 2: An important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J Clin Endocrinol Metab 2002; 87: 5695-5701
14. Diederich S, Hanke B, Oelkers W, Bähr V. Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11β-reduction. J Clin Endocrinol Metab 1997; 82: 1598-1602
15. Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, Diederich S, Bähr V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol 2002; 146: 789-799
16. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987; 237: 268-275
17. Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM. Functional domains of the human glucocorticoid receptor. Cell 1986; 46: 645-652
18. Chandler VL, Maler BA, Yamamoto KR. DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell 1983; 33: 489-499
19. Gellersen B, Kempf R, Telgmann R, DiMattia GE. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994; 8: 356-373
20. Lorenz WW, McCann RO, Longiaru M, Cormier MJ. Isolation and expression of a cDNA encoding Renilla reniformis luciferase. Proc Natl Acad Sci U S A 1991; 88: 4438-4442
21. Jenkins JS, Sampson PA. Conversion of cortisone to cortisol and prednisone to prednisolone. Br Med J 1967; 2: 205-207
22. Diederich S, Quinkler M, Burkhardt P, Großmann C, Bähr V, Oelkers W. 11β-Hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine. Eur J Clin Invest 2000; 30 (Suppl 3): 21-27
23. Escher G, Frey FJ, Frey BM. 11beta-Hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney. Endocrinology 1994; 135: 101-106
24. Oelkers W, Buchen S, Diederich S, Krain J, Muhme S, Schöneshö fer M. Impaired renal 11 beta-oxidation of 9 alpha-fluorocortisol: an explanation for its mineralocorticoid potency. J Clin Endocrinol Metab 1994; 78: 928-932
25. Ruers TJM, Buurman WA, van Boxtel CJ, van der Linden CJ, Kootstra G. Immunohistological observations in rat kidney allografts after local steroid administration. J Exp Med 1987; 166: 1205-1220
26. Ruers TJM, Buurman WA, Smits JFM, van der Linden CJ, van Dongen JJ, Struyker-Boudier HAJ, Kootstra G. Local treatment of renal allografts, a promising way to reduce the dosage of immunosuppressive drugs. Transplantation 1986; 41: 156-161
27. Fejes-Toth G, Pearce D, Naray-Fejes-Toth A. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci USA 1998; 95: 2973-2978
28. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997; 18: 306-36
29. Köppel H, Christ M, Yard BA, Bar PC, Van Der Woude FJ, Wehling M. Nongenomic effects of aldosterone on human renal cells. J Clin Endocrinol Metab 2003; 88: 1297-1302
30. Adcock IM. Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 2001; 14: 211-219
31. Haynes RCJ. Adrenocorticotropic hormone: Adrenocortical steroids and their synthetic analogs: Inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman Gilman A, Rall TW, Nies AS, Tayler P (eds). The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990: 1431-1462